N-Acetyltransferase 8-Like (GCN5-Related, Putative) (NAT8L) (C-Term) Peptide
Quick Overview for N-Acetyltransferase 8-Like (GCN5-Related, Putative) (NAT8L) (C-Term) Peptide (ABIN8106066)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- NAT8L Peptide - C-terminal region
-
Sequence
- VAAHKLYESL GFRHMGASDH YVLPGMTLSL AERLFFQVRY HRYRLQLREE
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-NAT8L Antibody (ARP49151_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- NAT8L (N-Acetyltransferase 8-Like (GCN5-Related, Putative) (NAT8L))
-
Background
-
Background Information: This gene encodes a single-pass membrane protein, which contains a conserved sequence of the GCN5 or NAT superfamily of N-acetyltransferases and is a member of the N-acyltransferase (NAT) superfamily. This protein is a neuron-specific protein and is the N-acetylaspartate (NAA) biosynthetic enzyme, catalyzing the NAA synthesis from L-aspartate and acetyl-CoA. NAA is a major storage and transport form of acetyl coenzyme A specific to the nervous system. The gene mutation results in primary NAA deficiency (hypoacetylaspartia).
Alternative Symbols: CML3, FLJ37478, MGC117272, NAT8-LIKE, NACED
-
Molecular Weight
- 15kDa
-
Gene ID
- 339983
-
NCBI Accession
- NP_848652
-
UniProt
- Q8N9F0
Target
-
